{"title":"横纹肌溶解和中毒性肌病","authors":"J. Kao, M. Milone","doi":"10.1093/MED/9780190862923.003.0096","DOIUrl":null,"url":null,"abstract":"Myopathies in patients in the intensive care unit are comparatively rare and often are due to critical illness (rhabdomyolysis, critical illness myopathy). Rhabdomyolysis is commonly a consequence of continuous muscle activity, such as in status epilepticus and serotonin syndrome. Toxic myopathies are caused by drug exposure. Recognition and management of these 2 major myopathies are discussed.","PeriodicalId":308040,"journal":{"name":"Mayo Clinic Critical and Neurocritical Care Board Review","volume":"223 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rhabdomyolysis and Toxic Myopathies\",\"authors\":\"J. Kao, M. Milone\",\"doi\":\"10.1093/MED/9780190862923.003.0096\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Myopathies in patients in the intensive care unit are comparatively rare and often are due to critical illness (rhabdomyolysis, critical illness myopathy). Rhabdomyolysis is commonly a consequence of continuous muscle activity, such as in status epilepticus and serotonin syndrome. Toxic myopathies are caused by drug exposure. Recognition and management of these 2 major myopathies are discussed.\",\"PeriodicalId\":308040,\"journal\":{\"name\":\"Mayo Clinic Critical and Neurocritical Care Board Review\",\"volume\":\"223 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mayo Clinic Critical and Neurocritical Care Board Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/MED/9780190862923.003.0096\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mayo Clinic Critical and Neurocritical Care Board Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/MED/9780190862923.003.0096","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Myopathies in patients in the intensive care unit are comparatively rare and often are due to critical illness (rhabdomyolysis, critical illness myopathy). Rhabdomyolysis is commonly a consequence of continuous muscle activity, such as in status epilepticus and serotonin syndrome. Toxic myopathies are caused by drug exposure. Recognition and management of these 2 major myopathies are discussed.